Last $36.61 USD
Change Today +0.16 / 0.44%
Volume 76.2K
BABY On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 3:29 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

natus medical inc (BABY) Snapshot

Open
$36.60
Previous Close
$36.45
Day High
$36.93
Day Low
$35.93
52 Week High
12/26/14 - $36.93
52 Week Low
01/2/14 - $21.11
Market Cap
1.2B
Average Volume 10 Days
188.9K
EPS TTM
$1.13
Shares Outstanding
32.5M
EX-Date
--
P/E TM
32.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for NATUS MEDICAL INC (BABY)

Related News

No related news articles were found.

natus medical inc (BABY) Related Businessweek News

No Related Businessweek News Found

natus medical inc (BABY) Details

Natus Medical Incorporated provides newborn care and neurology healthcare products worldwide. It offers healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The company’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and incubators to control the newborn’s environment; and software systems for managing and tracking disorders and diseases for public health laboratories. It provides ALGO, ABaer, AuDX, and Echo-Screen newborn hearing screeners; and hearing screening supply products that are used with newborn hearing screening devices. The company also offers diagnostic hearing assessment product lines, which include the Navigator Pro system, the Scout sport portable diagnostic device, and the AuDX PRO; and diagnostic hearing supply products. In addition, it provides monitoring systems, balance and mobility products, newborn brain injury diagnostic products, thermoregulation products, and jaundice management products. Further, the company offers photometers, radiometers, patient warming lamps, neonatal heatshields, pediatric scales, blanket warming cabinets, exam lights, oxygen hoods, restraining boards, and newborn circumstraint; neonatal noise attenuators, phototherapy eye masks, and x-ray shields for reproductive organs; and newborn screening data management products. It serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was founded in 1987 and is headquartered in San Carlos, California.

943 Employees
Last Reported Date: 03/17/14
Founded in 1987

natus medical inc (BABY) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $500.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $350.0K
Vice President and General Manager of Newborn...
Total Annual Compensation: $302.9K
Vice President and General Manager of Neurolo...
Total Annual Compensation: $265.0K
Vice President of Medical Affairs, Quality & ...
Total Annual Compensation: $257.0K
Compensation as of Fiscal Year 2013.

natus medical inc (BABY) Key Developments

Natus Medical Inc. Announces Unaudited Consolidated Financial Results for the Third Quarter and Year-to-Date Ended September 30, 2014; Provides Earnings Guidance for the Fourth Quarter of 2014; Revises Earnings Guidance for the Full Year 2014

Natus Medical Inc. announced unaudited consolidated financial results for the third quarter and year-to-date ended September 30, 2014. For the quarter, the company reported revenue of $89,876,000 against $85,392,000 a year ago. Income from operations was $12,766,000 against $9,138,000 a year ago. Income before tax was $11,319,000 against $8,558,000 a year ago. Net income was $7,786,000 or $0.24 diluted earnings per share against $6,287,000 or $0.20 diluted earnings per share a year ago. Non-GAAP income before provision for income tax was $15,553,000 against $12,319,000 for the same period in the last year. Non-GAAP net income was $10,607,000 or $0.33 diluted earnings per share against $9,088,000 or $0.30 basic and diluted earnings per share for the same period in the last year. Non-GAAP operating profit $17,000,000 against $12,899,000 for the same period in the last year. Cash flow from operations was approximately $16 million for the third quarter. For the year to date, the company reported revenue of $261,824,000 against $253,475,000 a year ago. Income from operations was $31,750,000 against $20,155,000 a year ago. Income before tax was $31,410,000 against $18,718,000 a year ago. Net income was $21,776,000 or $0.67 diluted earnings per share against $13,749,000 or $0.45 diluted earnings per share a year ago. Non-GAAP income before provision for income tax was $39,818,000 against $27,861,000 for the same period in the last year. Non-GAAP net income was $27,823,000 or $0.86 diluted earnings per share against $19,929,000 or $0.65 diluted earnings per share for the same period in the last year. Non-GAAP operating profit $40,158,000 against $29,298,000 for the same period in the last year. In the third quarter, the company generated $16 million in cash from operations. The company provided earnings guidance for the fourth quarter and revised earnings guidance for the full year 2014. For the fourth quarter of 2014, the company expects revenue of $92 million to $94 million and non-GAAP earnings per share of $0.37 to $0.39. It expects fourth quarter tax rate to increase slightly to about 34% as strength in domestic earnings is expected to continue. The company updated its non-GAAP earnings guidance for the full year 2014 and now expects to report non-GAAP earnings per share of $1.23 to $1.25, an increase from previous guidance of $1.20 to $1.23. Full year 2014 revenue guidance was increased to $353.8 million to $355.8 million compared to previous guidance of $347.5 million to $352.5 million. The company's non-GAAP earnings guidance excludes amortization of acquisition related intangibles, acquisition related charges, restructuring charges, and their related tax effects. Non-GAAP earnings guidance includes the impact of expensing employee share based compensation. All non-GAAP earnings per share amounts are on a diluted basis.

Natus Medical Incorporated Announces the Launch of the Vista Ultrasound System

Natus Medical Incorporated announced the launch of the Vista Ultrasound System. The Vista Ultrasound System is the first product in the market to enable the use of Ultrasound with an EMG workstation. The Vista Ultrasound System adds ultrasound capability to Natus' EDX and UltraPro S100 EMG workstations. The new Vista Ultrasound System will be available worldwide. The Vista Ultrasound system enables the performance of musculoskeletal and abdominal studies allowing the visualization of anatomic structures and landmarks useful in the diagnosis of peripheral nerve disorders. It is a complementary technology to EMG studies performed in the hospital or private practice. The Vista Ultrasound System is available with all new EDX and UltraPro S100 systems or as an upgrade to an existing system. It will be featured at the Natus Neurology booth at the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) and at the American Academy of Physical Medicine and Rehabilitation (AAPM&R) meetings.

Natus Medical Inc. to Report Q3, 2014 Results on Oct 22, 2014

Natus Medical Inc. announced that they will report Q3, 2014 results at 9:00 AM, Eastern Standard Time on Oct 22, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BABY:US $36.61 USD +0.16

BABY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CareFusion Corp $59.29 USD +0.11
NeuroMetrix Inc $1.74 USD -0.0316
NuVasive Inc $47.69 USD +0.32
Oxford Instruments PLC 1,257 GBp +14.00
View Industry Companies
 

Industry Analysis

BABY

Industry Average

Valuation BABY Industry Range
Price/Earnings 38.0x
Price/Sales 3.3x
Price/Book 3.5x
Price/Cash Flow 38.4x
TEV/Sales 3.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NATUS MEDICAL INC, please visit www.natus.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.